A DNA / HDAC dual‐targeting drug CY 190602 with significantly enhanced anticancer potency-Reference-Cited by-同舟云学术

A DNA / HDAC dual‐targeting drug CY 190602 with significantly enhanced anticancer potency

Published:2015-03-10 Issue:4 Volume:7 Page:438-449
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Liu Chuan¹²,Ding Hongyu¹,Li Xiaoxi¹,Pallasch Christian P³,Hong Liya⁴,Guo Dianwu⁴,Chen Yi⁵,Wang Difei⁶,Wang Wei⁷,Wang Yajie²,Hemann Michael T⁸,Jiang Hai¹

Affiliation:

1. Key Laboratory of Systems Biology, State Key Laboratory of Cell Biology Institute of Biochemistry and Cell Biology Shanghai Institutes for Biological Sciences Chinese Academy of Sciences Shanghai China

2. Department of Oncology Changhai Hospital Second Military Medical University Shanghai China

3. Clinic for Internal Medicine University Hospital of Cologne Cologne Germany

4. Hangzhou Minsheng Pharma Research Institute Ltd Hangzhou China

5. Crystal Biopharmaceutical LLC Pleasanton CA USA

6. Department of Biochemistry and Molecular & Cellular Biology Georgetown University Medical Center Washington DC USA

7. Department of Chemistry University of New Mexico Albuquerque NM USA

8. The Koch Institute for Integrative Cancer Research at MIT Massachusetts Institute of Technology Cambridge MA USA

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.201404580

Reference53 articles.

1. Deciphering the Binding between Nupr1 and MSL1 and Their DNA-Repairing Activity

2. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay;Alley MC;Cancer Res,1988

3. Chemotherapeutic agents circumvent emergence of dasatinib-resistant BCR-ABL kinase mutations in a precise mouse model of Philadelphia chromosome–positive acute lymphoblastic leukemia

4. Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy

5. Bendamustine: Rebirth of an Old Drug

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genome-wide CRISPR screening identifies critical role of phosphatase and tensin homologous (PTEN) in sensitivity of acute myeloid leukemia to chemotherapy;Journal of Zhejiang University-SCIENCE B;2024-08

2. Dual-targeting compounds possessing enhanced anticancer activity via microtubule disruption and histone deacetylase inhibition;European Journal of Medicinal Chemistry;2024-02

3. Dual inhibitors of HDAC and other epigenetic regulators: A novel strategy for cancer treatment;European Journal of Medicinal Chemistry;2024-01

4. Targeting histone deacetylases for cancer therapy: Trends and challenges;Acta Pharmaceutica Sinica B;2023-06

5. Hybrid Histone Deacetylase Inhibitor: An Effective Strategy for Cancer Therapy;Current Medicinal Chemistry;2023-06